Jennifer S. (laurence) Chadwick

Biography

Dr. Chadwick is Director of Biologic Development at BioAnalytix. Prior to joining BioAnalytix, Dr. Chadwick was a tenured Professor and Louise Byrd Graduate Educator in the Department of Pharmaceutical Chemistry at the University of Kansas. She is an expert in the analysis of proteins, and her academic research focused particularly on understanding the molecular mechanisms underlying instability of proteins and their stabilization by exogenous compounds. During her twelve years at KU, Prof. Chadwick also collaborated and consulted with numerous pharma/biotech companies to investigate stability problems and related formulations in therapeutic proteins, including monoclonal antibodies and antibody drug conjugates (ADCs), and she is an invited member of the Higher Order Structure (HOS) consortium. Her academic work spanned a diverse set of research problems, including biomaterials, and has resulted in over 50 peer-reviewed publications, 13 patents and 4 book chapters. Dr. Chadwick is an Editorial Advisory Board member for Journal of Pharmaceutical Sciences and Scientific Reports. She received her PhD form Purdue University, Department of Chemistry for her quantitative analysis of interactions between chemokines and a diverse set of partner molecules.

Research Interest

Pharmaceutical Chemistry